2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and Coronary Artery Disease

2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine has been researched along with Coronary Artery Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boxberger, M; Kherad, B; Krackhardt, F; Noutsias, M; Pansieri, M; Piot, C; Ríos, XF; Rischner, J; Ruiz-Poveda, FL; Waliszewski, M	1

Other Studies

1 other study(ies) available for 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and Coronary Artery Disease

Article	Year
Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6‑month vs. 12‑month dual-antiplatelet therapy (DAPT). Herz, 2019, Volume: 44, Issue:5 Topics: Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Dinucleoside Phosphates; Drug-Eluting Stents; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Sirolimus; Treatment Outcome	2019

Article

Year

Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6‑month vs. 12‑month dual-antiplatelet therapy (DAPT).

Herz, 2019, Volume: 44, Issue:5

Topics: Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Dinucleoside Phosphates; Drug-Eluting Stents; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Sirolimus; Treatment Outcome

2019